Glycated Hemoglobin [HbA1C] As a Dual Marker for Glycemic Status and Dyslipidemia in Diabetics: A Cross Sectional Analysis of 450 Cases

Journal Title: Indian Journal of Pathology: Research and Practice - Year 2017, Vol 6, Issue 2

Abstract

Background: The prevalence of dyslipidemia in diabetes mellitus [DM] is 95%. Diabetic patients with accompanied dyslipidemia are soft targets of cardiovascular deaths. Glycated Hemoglobin [HbA1C] the gold standard for assessing the glycemic status, has been regarded as an independent risk factor for Coronary Heart Disease [CHD] and stroke. Various studies have contradicting results on the impact ofHbA1C levels on lipid profile in diabetics. Aim: To find out association between glycemic control (HbA1C), age, gender and serum lipid profile in type 2 diabetic patients and non-diabetic subjects. Materials and Methods: A cross-sectional study carried out in SRM Hospital and Research Centre, Chennai. Total 450 subjects (150 controlled & 150 poorly controlled diabetics, 150 non-diabetics) with equal number of males and females in each group and investigated for HbA1C and lipid profile. Statistical Analysis: The data were analyzed by SPSS version 21 using Independent samples student ‘t’ test. ‘p’ value <0.05 was considered as statistically significant. Results: There was a significant increase in mean Total Cholesterol [TC], Triglyceride[TG], Low Density Lipoprotein Cholesterol [LDL-C], Fasting Blood Glucose [FBG] levels and HbA1C between non-diabetics, controlled and poorly controlled diabetics. But High Density Lipoprotein-Cholesterol [HDL-C] was not significant between these study groups. TC, TG, LDL-C levels between males and females in each group were not statistically significant. But mean HDL-C was non-significantly lower in female diabetics. Subjects with worse glycemic control (HbA1C >9%) possessed significantly high values of TC, TG, LDL-C, FBG except HDL-C. No significant correlation for age with respect to serum lipid profile. Conclusion: We conclude, HbA1C predicts dyslipidemia . This highlights the usefulness of HbA1C as dual biomarker (glycemic control and lipidemic state) for screening high risk diabetic patients.

Authors and Affiliations

Lavanya Rajagopal

Keywords

Related Articles

Role of HER-2/Neu Expression in Premalignant and Malignant Lesions of Uterine Cervix

Background: HER-2/neu is a gene localized on chromosome 17q21 which encodes a growth factor receptor like molecule with tyrosine kinase activity and is known to encode a transmembrane glycoprotein. Aim: To study the expr...

Evaluation of Fluorescent Staining for the Diagnosis of Leprosy in Tissue Sections and its Histopathological Correlation : Comparision with ZN Staining

Introduction: to study histopathological evaluation and its correlation with fluorescent staining used in the diagnosis of leprosy in tissue section and comparision of fluorescent staining with zn staining. Materials and...

Adenomatous Polyposis of Gall Bladder: A Rare Presentation in HCV Positive Female

Background: Gall bladder (GB) adenomatous polyps are uncommon and are usually an incidental finding. Infections serve as a fertile soil for gall bladder polyps. Risks for GB polyps are seen in patients with hepatitis B v...

Prevalence of Thyroid Lesions in a Rural Setting: A Cytological Study from a Tertiary Care Teaching Hospital

Background: The past few years have witnessed a global increase in the prevalence of thyroid cancer, and it is the fifth most common cancer in women. The study intends to estimate the prevalence of thyroid malignancies,...

Editorial

Not available

Download PDF file
  • EP ID EP464230
  • DOI 10.21088/ijprp.2278.148X.62(pt-II)17.13
  • Views 103
  • Downloads 0

How To Cite

Lavanya Rajagopal (2017). Glycated Hemoglobin [HbA1C] As a Dual Marker for Glycemic Status and Dyslipidemia in Diabetics: A Cross Sectional Analysis of 450 Cases. Indian Journal of Pathology: Research and Practice, 6(2), 415-420. https://europub.co.uk/articles/-A-464230